nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine triphosphate—ABCC2—Sulfasalazine—ankylosing spondylitis	0.158	0.228	CbGbCtD
Adenosine triphosphate—ABCB11—Dexamethasone—ankylosing spondylitis	0.15	0.216	CbGbCtD
Adenosine triphosphate—ABCC2—Dexamethasone—ankylosing spondylitis	0.079	0.114	CbGbCtD
Adenosine triphosphate—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0681	0.098	CbGbCtD
Adenosine triphosphate—ABCC2—Methotrexate—ankylosing spondylitis	0.0635	0.0914	CbGbCtD
Adenosine triphosphate—ABCB1—Betamethasone—ankylosing spondylitis	0.0443	0.0637	CbGbCtD
Adenosine triphosphate—ABCB1—Prednisolone—ankylosing spondylitis	0.0437	0.0629	CbGbCtD
Adenosine triphosphate—ABCB1—Prednisone—ankylosing spondylitis	0.0413	0.0594	CbGbCtD
Adenosine triphosphate—ARAF—vertebral column—ankylosing spondylitis	0.0317	0.283	CbGeAlD
Adenosine triphosphate—ABCB1—Dexamethasone—ankylosing spondylitis	0.0258	0.0371	CbGbCtD
Adenosine triphosphate—ABCB1—Methotrexate—ankylosing spondylitis	0.0207	0.0298	CbGbCtD
Adenosine triphosphate—ADRBK2—tendon—ankylosing spondylitis	0.0058	0.0518	CbGeAlD
Adenosine triphosphate—ABCG1—tendon—ankylosing spondylitis	0.00526	0.047	CbGeAlD
Adenosine triphosphate—ACVRL1—tendon—ankylosing spondylitis	0.00526	0.047	CbGeAlD
Adenosine triphosphate—HSPA1B—tendon—ankylosing spondylitis	0.00491	0.0438	CbGeAlD
Adenosine triphosphate—HSPA1A—tendon—ankylosing spondylitis	0.00491	0.0438	CbGeAlD
Adenosine triphosphate—ARAF—tendon—ankylosing spondylitis	0.00459	0.041	CbGeAlD
Adenosine triphosphate—ACVR1B—Hematopoietic Stem Cell Differentiation—IL1A—ankylosing spondylitis	0.00457	0.0264	CbGpPWpGaD
Adenosine triphosphate—ASNA1—tendon—ankylosing spondylitis	0.00431	0.0384	CbGeAlD
Adenosine triphosphate—ACVR1B—MAPK Signaling Pathway—IL1R2—ankylosing spondylitis	0.00426	0.0246	CbGpPWpGaD
Adenosine triphosphate—AFG3L2—tendon—ankylosing spondylitis	0.00425	0.038	CbGeAlD
Adenosine triphosphate—NAE1—tendon—ankylosing spondylitis	0.00415	0.037	CbGeAlD
Adenosine triphosphate—SLC25A4—tendon—ankylosing spondylitis	0.00386	0.0345	CbGeAlD
Adenosine triphosphate—APAF1—FAS pathway and Stress induction of HSP regulation—IL1A—ankylosing spondylitis	0.00374	0.0216	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—MAPK Signaling Pathway—IL1R2—ankylosing spondylitis	0.00356	0.0205	CbGpPWpGaD
Adenosine triphosphate—APAF1—Apoptosis—TNFRSF1B—ankylosing spondylitis	0.00352	0.0203	CbGpPWpGaD
Adenosine triphosphate—ADRBK2—Corticotropin-releasing hormone—TLR4—ankylosing spondylitis	0.00348	0.0201	CbGpPWpGaD
Adenosine triphosphate—ACSS1—tendon—ankylosing spondylitis	0.00343	0.0306	CbGeAlD
Adenosine triphosphate—ACVR1—tendon—ankylosing spondylitis	0.00335	0.0299	CbGeAlD
Adenosine triphosphate—NT5C2—tendon—ankylosing spondylitis	0.00335	0.0299	CbGeAlD
Adenosine triphosphate—APAF1—Apoptosis Modulation and Signaling—TNFRSF1B—ankylosing spondylitis	0.00331	0.0191	CbGpPWpGaD
Adenosine triphosphate—ACSS2—tendon—ankylosing spondylitis	0.00329	0.0293	CbGeAlD
Adenosine triphosphate—APAF1—TNF alpha Signaling Pathway—TNFRSF1B—ankylosing spondylitis	0.00328	0.0189	CbGpPWpGaD
Adenosine triphosphate—ACSL1—tendon—ankylosing spondylitis	0.00326	0.0291	CbGeAlD
Adenosine triphosphate—HSPA1A—Apoptosis Modulation and Signaling—TNFRSF1B—ankylosing spondylitis	0.00324	0.0187	CbGpPWpGaD
Adenosine triphosphate—ABL2—tendon—ankylosing spondylitis	0.0032	0.0286	CbGeAlD
Adenosine triphosphate—ABCG1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00301	0.0173	CbGpPWpGaD
Adenosine triphosphate—NAE1—Alzheimers Disease—TNF—ankylosing spondylitis	0.00288	0.0166	CbGpPWpGaD
Adenosine triphosphate—AKT1—tendon—ankylosing spondylitis	0.00282	0.0252	CbGeAlD
Adenosine triphosphate—ASNS—tendon—ankylosing spondylitis	0.00282	0.0252	CbGeAlD
Adenosine triphosphate—APAF1—p75(NTR)-mediated signaling—MMP3—ankylosing spondylitis	0.00266	0.0153	CbGpPWpGaD
Adenosine triphosphate—ASS1—tendon—ankylosing spondylitis	0.00246	0.0219	CbGeAlD
Adenosine triphosphate—SLC25A4—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.00242	0.0139	CbGpPWpGaD
Adenosine triphosphate—ABCC9—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00228	0.0131	CbGpPWpGaD
Adenosine triphosphate—AKT1—IL17 signaling pathway—IL17A—ankylosing spondylitis	0.00219	0.0126	CbGpPWpGaD
Adenosine triphosphate—ADK—tendon—ankylosing spondylitis	0.00215	0.0192	CbGeAlD
Adenosine triphosphate—ABCA1—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.00197	0.0114	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Leptin signaling pathway—IL1RN—ankylosing spondylitis	0.00184	0.0106	CbGpPWpGaD
Adenosine triphosphate—APAF1—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—ankylosing spondylitis	0.00172	0.00989	CbGpPWpGaD
Adenosine triphosphate—AKT1—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.00169	0.00975	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.00167	0.00962	CbGpPWpGaD
Adenosine triphosphate—ABCA1—Folate Metabolism—CRP—ankylosing spondylitis	0.0016	0.00925	CbGpPWpGaD
Adenosine triphosphate—ABL1—tendon—ankylosing spondylitis	0.00154	0.0138	CbGeAlD
Adenosine triphosphate—APAF1—Amyotrophic lateral sclerosis (ALS)—TNF—ankylosing spondylitis	0.00153	0.00884	CbGpPWpGaD
Adenosine triphosphate—ABCA1—RXR and RAR heterodimerization with other nuclear receptor—TNF—ankylosing spondylitis	0.00153	0.00882	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.00145	0.00836	CbGpPWpGaD
Adenosine triphosphate—APAF1—FAS pathway and Stress induction of HSP regulation—TNF—ankylosing spondylitis	0.00141	0.00816	CbGpPWpGaD
Adenosine triphosphate—AKT1—Regulation of nuclear SMAD2/3 signaling—RUNX3—ankylosing spondylitis	0.0014	0.00807	CbGpPWpGaD
Adenosine triphosphate—ABCC2—tendon—ankylosing spondylitis	0.00134	0.0119	CbGeAlD
Adenosine triphosphate—AKT1—CD40/CD40L signaling—CD40LG—ankylosing spondylitis	0.00132	0.00763	CbGpPWpGaD
Adenosine triphosphate—ABCA1—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.00127	0.00735	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Host Interactions of HIV factors—HLA-A—ankylosing spondylitis	0.00125	0.0072	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.00121	0.00698	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.0012	0.00693	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.00119	0.00689	CbGpPWpGaD
Adenosine triphosphate—ADCY1—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00116	0.0067	CbGpPWpGaD
Adenosine triphosphate—AKT1—MAPK Signaling Pathway—IL1R2—ankylosing spondylitis	0.00114	0.00657	CbGpPWpGaD
Adenosine triphosphate—AKT1—a6b1 and a6b4 Integrin signaling—IL1A—ankylosing spondylitis	0.00111	0.00642	CbGpPWpGaD
Adenosine triphosphate—AKT1—Apoptosis—TNFRSF1B—ankylosing spondylitis	0.00111	0.00639	CbGpPWpGaD
Adenosine triphosphate—APAF1—Caspase Cascade in Apoptosis—TNF—ankylosing spondylitis	0.00111	0.00639	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00107	0.00615	CbGpPWpGaD
Adenosine triphosphate—ABL1—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—ankylosing spondylitis	0.00106	0.00611	CbGpPWpGaD
Adenosine triphosphate—AKT1—TNF alpha Signaling Pathway—TNFRSF1B—ankylosing spondylitis	0.00103	0.00594	CbGpPWpGaD
Adenosine triphosphate—AKT1—Leptin signaling pathway—IL1RN—ankylosing spondylitis	0.00103	0.00593	CbGpPWpGaD
Adenosine triphosphate—AKT1—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000988	0.00569	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000983	0.00566	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000976	0.00563	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—ANTXR2—ankylosing spondylitis	0.000966	0.00557	CbGpPWpGaD
Adenosine triphosphate—AKT1—IL-6 signaling pathway—CRP—ankylosing spondylitis	0.000965	0.00556	CbGpPWpGaD
Adenosine triphosphate—AKT1—IL-1 signaling pathway—IL1A—ankylosing spondylitis	0.000948	0.00547	CbGpPWpGaD
Adenosine triphosphate—ADCY1—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000942	0.00543	CbGpPWpGaD
Adenosine triphosphate—AKT1—TCR Signaling Pathway—IL17A—ankylosing spondylitis	0.000935	0.00539	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Cellular responses to stress—IL1A—ankylosing spondylitis	0.000914	0.00527	CbGpPWpGaD
Adenosine triphosphate—AKT1—IL6-mediated signaling events—CRP—ankylosing spondylitis	0.000899	0.00518	CbGpPWpGaD
Adenosine triphosphate—ABCA1—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.000893	0.00515	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—ANTXR2—ankylosing spondylitis	0.000891	0.00514	CbGpPWpGaD
Adenosine triphosphate—AKT1—Oncostatin M Signaling Pathway—MMP3—ankylosing spondylitis	0.000877	0.00506	CbGpPWpGaD
Adenosine triphosphate—AKT1—IL4-mediated signaling events—IL10—ankylosing spondylitis	0.000857	0.00494	CbGpPWpGaD
Adenosine triphosphate—AKT1—IL4-mediated signaling events—CD40LG—ankylosing spondylitis	0.000857	0.00494	CbGpPWpGaD
Adenosine triphosphate—AKT1—TCR signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000856	0.00493	CbGpPWpGaD
Adenosine triphosphate—APAF1—Alzheimers Disease—TNF—ankylosing spondylitis	0.000853	0.00492	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Cellular responses to stress—IL1A—ankylosing spondylitis	0.000843	0.00486	CbGpPWpGaD
Adenosine triphosphate—AKT1—p75(NTR)-mediated signaling—MMP3—ankylosing spondylitis	0.000836	0.00482	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—ANTXR2—ankylosing spondylitis	0.000834	0.00481	CbGpPWpGaD
Adenosine triphosphate—APAF1—Apoptosis—TNF—ankylosing spondylitis	0.000812	0.00468	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—HIV Infection—HLA-A—ankylosing spondylitis	0.000811	0.00468	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000798	0.0046	CbGpPWpGaD
Adenosine triphosphate—AKT1—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	0.000787	0.00454	CbGpPWpGaD
Adenosine triphosphate—ASNS—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000775	0.00447	CbGpPWpGaD
Adenosine triphosphate—APAF1—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	0.000755	0.00436	CbGpPWpGaD
Adenosine triphosphate—AKT1—B Cell Receptor Signaling Pathway—CD79A—ankylosing spondylitis	0.000735	0.00423	CbGpPWpGaD
Adenosine triphosphate—ABCA1—Folate Metabolism—TNF—ankylosing spondylitis	0.000726	0.00419	CbGpPWpGaD
Adenosine triphosphate—ABL1—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.00072	0.00415	CbGpPWpGaD
Adenosine triphosphate—AKT1—Regulation of nuclear SMAD2/3 signaling—IL10—ankylosing spondylitis	0.000692	0.00399	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—KIR3DL1—ankylosing spondylitis	0.000674	0.00389	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000673	0.00388	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—KIR3DL1—ankylosing spondylitis	0.000646	0.00373	CbGpPWpGaD
Adenosine triphosphate—AKT1—TCR Signaling Pathway—IL1A—ankylosing spondylitis	0.000639	0.00369	CbGpPWpGaD
Adenosine triphosphate—ABCG1—Metabolism—B3GNT2—ankylosing spondylitis	0.000629	0.00363	CbGpPWpGaD
Adenosine triphosphate—AKT1—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.000614	0.00354	CbGpPWpGaD
Adenosine triphosphate—AKT1—Primary Focal Segmental Glomerulosclerosis FSGS—TLR4—ankylosing spondylitis	0.000613	0.00353	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—CARD9—ankylosing spondylitis	0.000608	0.0035	CbGpPWpGaD
Adenosine triphosphate—ACVR1—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.000606	0.0307	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.000606	0.0307	CbGdCrCtD
Adenosine triphosphate—ACVR1—Dexamethasone—Betamethasone—ankylosing spondylitis	0.000596	0.0302	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Dexamethasone—ankylosing spondylitis	0.000596	0.0302	CbGdCrCtD
Adenosine triphosphate—AKT1—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000595	0.00343	CbGpPWpGaD
Adenosine triphosphate—ABCC2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000586	0.00338	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—CARD9—ankylosing spondylitis	0.000583	0.00336	CbGpPWpGaD
Adenosine triphosphate—ACVR1—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.000583	0.0295	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Triamcinolone—ankylosing spondylitis	0.000583	0.0295	CbGdCrCtD
Adenosine triphosphate—ADRBK1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000581	0.00335	CbGpPWpGaD
Adenosine triphosphate—ABCA1—Selenium Micronutrient Network—TNF—ankylosing spondylitis	0.000577	0.00333	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—B3GNT2—ankylosing spondylitis	0.000569	0.00328	CbGpPWpGaD
Adenosine triphosphate—NT5C2—Metabolism—B3GNT2—ankylosing spondylitis	0.000561	0.00323	CbGpPWpGaD
Adenosine triphosphate—ADCY1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000557	0.00321	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000556	0.00321	CbGpPWpGaD
Adenosine triphosphate—ACVR1—Betamethasone—Prednisone—ankylosing spondylitis	0.000553	0.028	CbGdCrCtD
Adenosine triphosphate—ACVR1—Dexamethasone—Prednisone—ankylosing spondylitis	0.000553	0.028	CbGdCrCtD
Adenosine triphosphate—ACVR1B—MAPK Signaling Pathway—TNF—ankylosing spondylitis	0.000549	0.00316	CbGpPWpGaD
Adenosine triphosphate—ACVR1—Dexamethasone—Prednisolone—ankylosing spondylitis	0.00054	0.0274	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Prednisolone—ankylosing spondylitis	0.00054	0.0274	CbGdCrCtD
Adenosine triphosphate—ACSS1—Metabolism—B3GNT2—ankylosing spondylitis	0.000527	0.00304	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—B3GNT2—ankylosing spondylitis	0.000525	0.00303	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Flurandrenolide—Methylprednisolone—ankylosing spondylitis	0.000521	0.0264	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Flurandrenolide—Betamethasone—ankylosing spondylitis	0.000513	0.026	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Flurandrenolide—Dexamethasone—ankylosing spondylitis	0.000513	0.026	CbGdCrCtD
Adenosine triphosphate—AKT1—Corticotropin-releasing hormone—TLR4—ankylosing spondylitis	0.000504	0.0029	CbGpPWpGaD
Adenosine triphosphate—ACSS2—Metabolism—B3GNT2—ankylosing spondylitis	0.0005	0.00288	CbGpPWpGaD
Adenosine triphosphate—APAF1—Apoptosis—TNF—ankylosing spondylitis	0.000498	0.00287	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—B3GNT2—ankylosing spondylitis	0.000491	0.00283	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—ANTXR2—ankylosing spondylitis	0.000472	0.00272	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000464	0.00268	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Flurandrenolide—Prednisolone—ankylosing spondylitis	0.000464	0.0235	CbGdCrCtD
Adenosine triphosphate—AKT1—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.000464	0.00267	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—MAPK Signaling Pathway—TNF—ankylosing spondylitis	0.000458	0.00264	CbGpPWpGaD
Adenosine triphosphate—ASS1—Metabolism—B3GNT2—ankylosing spondylitis	0.000457	0.00263	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.000455	0.00262	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—ANTXR2—ankylosing spondylitis	0.000452	0.00261	CbGpPWpGaD
Adenosine triphosphate—AKT1—TWEAK Signaling Pathway—TNF—ankylosing spondylitis	0.000445	0.00257	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Triamcinolone—Methylprednisolone—ankylosing spondylitis	0.000433	0.0219	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Triamcinolone—Dexamethasone—ankylosing spondylitis	0.000426	0.0216	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Triamcinolone—Betamethasone—ankylosing spondylitis	0.000426	0.0216	CbGdCrCtD
Adenosine triphosphate—ADK—Metabolism—B3GNT2—ankylosing spondylitis	0.000425	0.00245	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.000424	0.00245	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000422	0.0214	CbGdCrCtD
Adenosine triphosphate—APAF1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	0.000421	0.00243	CbGpPWpGaD
Adenosine triphosphate—AKT1—B Cell Activation—CD79A—ankylosing spondylitis	0.00042	0.00242	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000415	0.0211	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000415	0.0211	CbGdCrCtD
Adenosine triphosphate—ACSL1—Metabolism—B3GNT2—ankylosing spondylitis	0.000411	0.00237	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Metabolism—B3GNT2—ankylosing spondylitis	0.000411	0.00237	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—IL1R2—ankylosing spondylitis	0.000408	0.00235	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—KIR3DL1—ankylosing spondylitis	0.000408	0.00235	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000406	0.0206	CbGdCrCtD
Adenosine triphosphate—AKT1—Ceramide signaling pathway—TNF—ankylosing spondylitis	0.0004	0.00231	CbGpPWpGaD
Adenosine triphosphate—ASNS—Metabolism—B3GNT2—ankylosing spondylitis	0.000399	0.0023	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Diflorasone—Methylprednisolone—ankylosing spondylitis	0.000399	0.0202	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Methylprednisolone—ankylosing spondylitis	0.000398	0.0202	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Triamcinolone—Prednisone—ankylosing spondylitis	0.000395	0.02	CbGdCrCtD
Adenosine triphosphate—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	0.000395	0.00227	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Diflorasone—Dexamethasone—ankylosing spondylitis	0.000393	0.0199	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Diflorasone—Betamethasone—ankylosing spondylitis	0.000393	0.0199	CbGdCrCtD
Adenosine triphosphate—ADCY1—Immune System—IL1R2—ankylosing spondylitis	0.000392	0.00226	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Betamethasone—ankylosing spondylitis	0.000391	0.0198	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Dexamethasone—ankylosing spondylitis	0.000391	0.0198	CbGdCrCtD
Adenosine triphosphate—AKT1—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.000388	0.00224	CbGpPWpGaD
Adenosine triphosphate—AKT1—Angiopoietin receptor Tie2-mediated signaling—TNF—ankylosing spondylitis	0.000387	0.00223	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—ERAP1—ankylosing spondylitis	0.000387	0.00223	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—KIR3DL1—ankylosing spondylitis	0.000387	0.00223	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000387	0.00223	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Triamcinolone—Prednisolone—ankylosing spondylitis	0.000386	0.0195	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Diflorasone—Triamcinolone—ankylosing spondylitis	0.000384	0.0194	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Triamcinolone—ankylosing spondylitis	0.000382	0.0194	CbGdCrCtD
Adenosine triphosphate—ADRBK1—Innate Immune System—HLA-C—ankylosing spondylitis	0.000382	0.0022	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—ERAP1—ankylosing spondylitis	0.000371	0.00214	CbGpPWpGaD
Adenosine triphosphate—AKT1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—ankylosing spondylitis	0.00037	0.00213	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—CARD9—ankylosing spondylitis	0.000368	0.00212	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—HLA-C—ankylosing spondylitis	0.000366	0.00211	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Diflorasone—Prednisone—ankylosing spondylitis	0.000364	0.0185	CbGdCrCtD
Adenosine triphosphate—AKT1—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.000362	0.00209	CbGpPWpGaD
Adenosine triphosphate—AKT1—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.000359	0.00207	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Diflorasone—Prednisolone—ankylosing spondylitis	0.000355	0.018	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Prednisolone—ankylosing spondylitis	0.000354	0.018	CbGdCrCtD
Adenosine triphosphate—ADRBK1—Immune System—CARD9—ankylosing spondylitis	0.000354	0.00204	CbGpPWpGaD
Adenosine triphosphate—AKT1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000352	0.00203	CbGpPWpGaD
Adenosine triphosphate—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—ankylosing spondylitis	0.00035	0.00202	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Budesonide—Methylprednisolone—ankylosing spondylitis	0.00035	0.0177	CbGdCrCtD
Adenosine triphosphate—ABL1—Innate Immune System—CARD9—ankylosing spondylitis	0.000349	0.00201	CbGpPWpGaD
Adenosine triphosphate—AKT1—Caspase Cascade in Apoptosis—TNF—ankylosing spondylitis	0.000349	0.00201	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Budesonide—Dexamethasone—ankylosing spondylitis	0.000344	0.0174	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Budesonide—Betamethasone—ankylosing spondylitis	0.000344	0.0174	CbGdCrCtD
Adenosine triphosphate—ADCY1—Immune System—CARD9—ankylosing spondylitis	0.000339	0.00196	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Budesonide—Triamcinolone—ankylosing spondylitis	0.000336	0.017	CbGdCrCtD
Adenosine triphosphate—ABCA1—Metabolism—B3GNT2—ankylosing spondylitis	0.00033	0.0019	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Budesonide—Prednisone—ankylosing spondylitis	0.000319	0.0162	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Budesonide—Prednisolone—ankylosing spondylitis	0.000312	0.0158	CbGdCrCtD
Adenosine triphosphate—ACVR1B—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000302	0.00174	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	0.00029	0.00167	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	0.000289	0.00166	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	0.000289	0.00166	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—ANTXR2—ankylosing spondylitis	0.000286	0.00165	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—B3GNT2—ankylosing spondylitis	0.000278	0.0016	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000276	0.00159	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	0.000274	0.00158	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—B3GNT2—ankylosing spondylitis	0.000266	0.00154	CbGpPWpGaD
Adenosine triphosphate—AKT1—Apoptosis—TNF—ankylosing spondylitis	0.000256	0.00147	CbGpPWpGaD
Adenosine triphosphate—AKT1—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000256	0.00147	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	0.000254	0.00147	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000249	0.00143	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IL1R2—ankylosing spondylitis	0.000247	0.00143	CbGpPWpGaD
Adenosine triphosphate—ADCY1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000239	0.00138	CbGpPWpGaD
Adenosine triphosphate—AKT1—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	0.000238	0.00137	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IL1R2—ankylosing spondylitis	0.000235	0.00135	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—ERAP1—ankylosing spondylitis	0.000235	0.00135	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Developmental Biology—TNF—ankylosing spondylitis	0.000232	0.00134	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—HLA-C—ankylosing spondylitis	0.000231	0.00133	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—HLA-A—ankylosing spondylitis	0.00023	0.00133	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000226	0.0013	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—HLA-B—ankylosing spondylitis	0.000226	0.0013	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—B3GNT2—ankylosing spondylitis	0.000223	0.00129	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—HLA-C—ankylosing spondylitis	0.000222	0.00128	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—ERAP1—ankylosing spondylitis	0.000222	0.00128	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000222	0.00128	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—HLA-C—ankylosing spondylitis	0.000219	0.00126	CbGpPWpGaD
Adenosine triphosphate—AKT1—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.000219	0.00126	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000217	0.00125	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—HLA-B—ankylosing spondylitis	0.000216	0.00125	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—MMP3—ankylosing spondylitis	0.000215	0.00124	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CARD9—ankylosing spondylitis	0.000215	0.00124	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.000214	0.0108	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.000214	0.0108	CbGdCrCtD
Adenosine triphosphate—ADCY1—Immune System—HLA-C—ankylosing spondylitis	0.000213	0.00123	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—HLA-A—ankylosing spondylitis	0.000213	0.00123	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Betamethasone—Dexamethasone—ankylosing spondylitis	0.000211	0.0107	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Betamethasone—ankylosing spondylitis	0.000211	0.0107	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Betamethasone—Triamcinolone—ankylosing spondylitis	0.000206	0.0104	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.000206	0.0104	CbGdCrCtD
Adenosine triphosphate—ABCC8—Metabolism—B3GNT2—ankylosing spondylitis	0.000204	0.00118	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CARD9—ankylosing spondylitis	0.000203	0.00117	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—CRP—ankylosing spondylitis	0.0002	0.00115	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—HLA-A—ankylosing spondylitis	0.000199	0.00115	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Betamethasone—Prednisone—ankylosing spondylitis	0.000195	0.0099	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Prednisone—ankylosing spondylitis	0.000195	0.0099	CbGdCrCtD
Adenosine triphosphate—ADRBK1—Immune System—IL1RN—ankylosing spondylitis	0.000193	0.00111	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—TLR4—ankylosing spondylitis	0.000191	0.0011	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—CRP—ankylosing spondylitis	0.000191	0.0011	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Betamethasone—Prednisolone—ankylosing spondylitis	0.000191	0.00966	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Prednisolone—ankylosing spondylitis	0.000191	0.00966	CbGdCrCtD
Adenosine triphosphate—ADCY1—Immune System—IL1RN—ankylosing spondylitis	0.000185	0.00107	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—TLR4—ankylosing spondylitis	0.000183	0.00106	CbGpPWpGaD
Adenosine triphosphate—AKT1—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	0.000171	0.000985	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—CD79A—ankylosing spondylitis	0.00017	0.000978	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000169	0.000977	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—B3GNT2—ankylosing spondylitis	0.000168	0.000971	CbGpPWpGaD
Adenosine triphosphate—ABL2—Developmental Biology—TNF—ankylosing spondylitis	0.000166	0.000959	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—CD79A—ankylosing spondylitis	0.000163	0.000937	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—B3GNT2—ankylosing spondylitis	0.000161	0.00093	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000161	0.000928	CbGpPWpGaD
Adenosine triphosphate—AKT1—Apoptosis—TNF—ankylosing spondylitis	0.000157	0.000903	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000154	0.000889	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000151	0.000869	CbGpPWpGaD
Adenosine triphosphate—AKT1—MAPK Signaling Pathway—TNF—ankylosing spondylitis	0.000147	0.000847	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000145	0.000835	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—B3GNT2—ankylosing spondylitis	0.000141	0.000813	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—IL1A—ankylosing spondylitis	0.000139	0.000802	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—CD40LG—ankylosing spondylitis	0.000138	0.000797	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000138	0.000796	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000137	0.000789	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—HLA-B—ankylosing spondylitis	0.000137	0.000789	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HLA-C—ankylosing spondylitis	0.000135	0.000777	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000134	0.00077	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—IL1A—ankylosing spondylitis	0.000133	0.000768	CbGpPWpGaD
Adenosine triphosphate—AKT1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	0.000133	0.000764	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—CD40LG—ankylosing spondylitis	0.000133	0.000764	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—HLA-B—ankylosing spondylitis	0.000131	0.000758	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000131	0.000757	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—HLA-B—ankylosing spondylitis	0.00013	0.000748	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000128	0.000738	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HLA-C—ankylosing spondylitis	0.000128	0.000736	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—HLA-B—ankylosing spondylitis	0.000126	0.000727	CbGpPWpGaD
Adenosine triphosphate—ABL1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	0.000126	0.000724	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—HLA-A—ankylosing spondylitis	0.000122	0.000702	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000122	0.000702	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—CRP—ankylosing spondylitis	0.000121	0.000697	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IL1RN—ankylosing spondylitis	0.000117	0.000675	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—HLA-A—ankylosing spondylitis	0.000117	0.000673	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—CRP—ankylosing spondylitis	0.000116	0.00067	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—TLR4—ankylosing spondylitis	0.000116	0.000668	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—CRP—ankylosing spondylitis	0.000115	0.000661	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—HLA-A—ankylosing spondylitis	0.000112	0.000648	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—CRP—ankylosing spondylitis	0.000111	0.000642	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—TLR4—ankylosing spondylitis	0.000111	0.000642	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IL1RN—ankylosing spondylitis	0.000111	0.00064	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—TLR4—ankylosing spondylitis	0.00011	0.000633	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	0.00011	0.000633	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—HLA-A—ankylosing spondylitis	0.000108	0.000622	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—TLR4—ankylosing spondylitis	0.000107	0.000616	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—MMP3—ankylosing spondylitis	0.000103	0.000595	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CD79A—ankylosing spondylitis	0.000103	0.000592	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—MMP3—ankylosing spondylitis	9.75e-05	0.000562	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CD79A—ankylosing spondylitis	9.74e-05	0.000562	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MMP3—ankylosing spondylitis	9.51e-05	0.000548	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MMP3—ankylosing spondylitis	9.11e-05	0.000525	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IL1A—ankylosing spondylitis	8.42e-05	0.000486	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CD40LG—ankylosing spondylitis	8.37e-05	0.000483	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PTGER4—ankylosing spondylitis	8.09e-05	0.000466	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IL1A—ankylosing spondylitis	7.99e-05	0.00046	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HLA-B—ankylosing spondylitis	7.97e-05	0.000459	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CD40LG—ankylosing spondylitis	7.94e-05	0.000458	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HLA-B—ankylosing spondylitis	7.55e-05	0.000435	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HLA-A—ankylosing spondylitis	7.38e-05	0.000426	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CRP—ankylosing spondylitis	7.04e-05	0.000406	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HLA-A—ankylosing spondylitis	7e-05	0.000403	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—HLA-A—ankylosing spondylitis	6.81e-05	0.000393	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—TLR4—ankylosing spondylitis	6.75e-05	0.000389	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CRP—ankylosing spondylitis	6.68e-05	0.000385	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—TLR4—ankylosing spondylitis	6.4e-05	0.000369	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—TNF—ankylosing spondylitis	6.2e-05	0.000357	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—TNF—ankylosing spondylitis	5.87e-05	0.000339	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	5.77e-05	0.000332	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MMP3—ankylosing spondylitis	5.76e-05	0.000332	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	5.42e-05	0.000312	CbGpPWpGaD
